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Abstract 36 
Pain might be an important risk factor for common mental disorders. Insight into the longitudinal association between pain 37 
and subsequent common mental disorders in the general adult population could help improve prevention and treatment 38 
strategies. Data were used from two waves of the Netherlands Mental Health Survey and Incidence Study-2, which is based 39 
on a multistage, stratified random sampling of households (N=5,303). Persons without a mental disorder 12 months prior to 40 
baseline were selected as the at-risk group (n=4,974 for any mood disorder; n=4,979 for any anxiety disorder; n=5,073 for 41 
any substance use disorder). Pain severity and interference due to pain in the past month were measured at baseline using 42 
the 36-item Short Form Health Survey. DSM-IV mental disorders were assessed at both waves using the Composite 43 
International Diagnostic Interview version 3.0. Moderate to very severe pain was associated with a higher risk for mood 44 
(OR=2.10, 95%CI=1.33-3.29) and anxiety disorders (OR=2.12, 95%CI=1.27-3.55) at follow-up. Moderate to very severe 45 
interference due to pain was also associated with a higher risk for mood (OR=2.14, 95%CI=1.30-3.54) and anxiety disorders 46 
(OR=1.92, 95%CI=1.05-3.52) at follow-up. Pain was not significantly associated with substance use disorders. No interaction 47 
effects were found between pain severity or interference due to pain and a previous history of mental disorders. Moderate 48 
to severe pain and interference due to pain are strong risk factors for first-incident and recurrent mood and anxiety disorders, 49 
independent of other mental disorders. Pain management programs could therefore possibly also serve as a preventative 50 
program for mental disorders.  51 
 52 
 53 
  54 
3 
 
Introduction 55 
According to the International Association for the Study of Pain (IASP), pain is ‘an unpleasant sensory 56 
and emotional experience associated with actual or potential tissue damage, or described in terms of 57 
such damage’ [6]. 19% of the adult European population suffers from moderate to severe pain [7]. Pain 58 
has substantial impact on quality of life and mental health. Thorough research exists examining the 59 
prevalence and cross-sectional association between pain and common mental disorders in population 60 
based [e.g. 3,22] and clinical studies [e.g. 2,11,20,23,24]. The economic and societal burden of pain and 61 
common mental disorders is high [2,16,20,28], and therefore composes a relevant public health 62 
problem. A better understanding of the prospective contribution of pain in mental disorders might be 63 
instrumental in identifying better strategies for prevention and early interventions of mental disorders, 64 
particularly because pain is modifiable. However, results of longitudinal studies, assessing the effect of 65 
pain on first-incident and recurrent mental disorders, are scarce.  66 
In studies from clinical settings [10,13,14] a longitudinal association between pain and mental disorders 67 
was found. Among at-risk stimulant (cocaine and methamphetamine) users, subjects with a higher 68 
number of days with pain (which interfered with work and social activities) were more likely to develop 69 
alcohol and opioid abuse/dependence compared to subjects without pain [10]. In two studies from the 70 
Netherlands Study of Depression and Anxiety (NESDA) - one among subjects with no previous history of 71 
and no current depressive or anxiety disorder [13], and one among subjects with a remitted depressive 72 
or anxiety disorder [14] - a higher number of pain locations and more severe pain were associated with 73 
the onset of a depressive and anxiety disorder, and with the recurrence of a depressive disorder. 74 
However, the extent to which results from these clinical studies can be generalized to the general 75 
population is unknown, and these results therefore need to be replicated and validated in population-76 
based studies. 77 
Several population-based studies have investigated such a longitudinal association between pain and 78 
symptoms of depression [1,12,18] and of anxiety [1,12]. In non-depressed subjects, those with 79 
moderate to severe interference due to pain [1], more severe pain [18], and chronic low back pain [12] 80 
were more likely to report depressive symptoms at follow-up, compared to those without pain. In non-81 
anxious subjects, the same results were found for moderate to severe interference due to pain [1] and 82 
chronic low back pain [12]. After adjusting for affective disorder at baseline, the strength of the pain-83 
affect associations was weakened [1], suggesting they modify each other’s association with pain. 84 
However, the results of these studies are limited as they focus on an elderly population [1,18], and relied 85 
on self-report questionnaires to measure symptoms of mental health problems in the last week [1,12,18] 86 
rather than on standardized diagnostic interviews to assess current and history of mental disorders. 87 
Furthermore, these studies focus either on depression and anxiety or on substance use disorders only, 88 
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but as these are among the most common mental disorders in adults [28], they should be studied in 89 
concert. This study aims to address these gaps. 90 
 91 
Methods 92 
Setting and participants 93 
In short, the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2) has a longitudinal 94 
epidemiological cohort design. This study was conducted among the Dutch general population aged 18–95 
64 years. It is based on a multistage, stratified random sampling of households, with one respondent 96 
randomly selected in each household. In the first wave (T0), performed from November 2007 to July 97 
2009, a total of 6,646 persons were interviewed (response rate 65.1%; average interview duration 95 98 
min). This sample was nationally representative, although younger subjects were somewhat under-99 
represented [5]. All T0 respondents were approached for follow-up (T1) three years after T0, from 100 
November 2010 to June 2012. Of this group, 5,303 persons were re-interviewed (response rate 80.4%, 101 
excluding those deceased; average interview duration 84 min). Attrition rate was not significantly 102 
associated with all main categories of mental disorders (mood, anxiety, and substance use) and 103 
individual 12-month mental disorders at baseline, after controlling for sociodemographic characteristics 104 
(Graaf 2013). More severe pain was, however, significantly associated with less attrition (OR=.91; p=.01), 105 
after adjustment for sociodemographic characteristics. The interviews were laptop computer assisted 106 
and almost all were held at the respondent’s home. The mean period between both interviews was three 107 
years and seven days. The Medical Ethics Committee for Institutions on Mental Health Care (METIGG) 108 
approved the study. After having been informed about the study objective, respondents provided written 109 
informed consent. A more comprehensive description of the design is provided in De Graaf et al. (2010) 110 
[15]. 111 
For this study, three at-risk groups were selected: 1) subjects without any mood disorder 12 months 112 
prior to baseline (n=4,974); 2) subjects without any anxiety disorder 12 months prior to baseline 113 
(n=4,979); and 3) subjects without any substance use disorder 12 months prior to baseline (n=5,073).  114 
However, it was possible for subjects in each of these at-risk groups to have a mental disorder of the 115 
other groups at baseline. For example, participants in the at-risk group for mood disorders, thus not 116 
reporting a mood disorder 12 months prior to baseline, could have an anxiety or substance use disorder 117 
12 months prior to baseline. Lifetime mental disorder was not an exclusion criterion. Therefore, subjects 118 
who reported a mental disorder between T0 and T1 are either a first incident case or recurrent case 119 
(hereafter called: incidence). Data were used from the first two waves of NEMESIS-2. 120 
 121 
Variables 122 
Commented [EdH1]: de Graaf, R., van Dorsselaer, 
S., Tuithof, M., & ten Have, M. (2013). 
Sociodemographic and psychiatric predictors of 
attrition in a prospective psychiatric epidemiological 
study among the general population. Result of the 
Netherlands Mental Health Survey and Incidence 
Study-2. Comprehensive Psychiatry, 54(8), 1131-
1139. 
5 
 
Dependent variables: Mental disorders 123 
Mental disorders were assessed using the Composite International Diagnostic Interview (CIDI) version 124 
3.0, a fully structured lay-administered diagnostic interview of mental disorders [21]. The CIDI was 125 
developed and adapted for use in the World Mental Health Survey Initiative. In the Netherlands, the CIDI 126 
3.0 was first used in ESEMeD, which is part of this initiative [4]. The CIDI 3.0 version used in NEMESIS-2 127 
was an improvement of the one used in the Dutch ESEMeD study. The mental disorders considered in 128 
this paper include: any mood disorder (major depression, dysthymia, bipolar disorder), any anxiety 129 
disorder (panic disorder, agoraphobia, social anxiety disorder, generalised anxiety disorder) and any 130 
substance use disorder (alcohol/drug abuse and dependence). Research has demonstrated acceptable 131 
reliability and validity for assessing these common mental disorders [17]. The appearance of any 132 
common mental disorder (i.e. any mood, anxiety or substance use disorder) between baseline and 133 
follow-up was the outcome variable of this study.  134 
At baseline, respondents were asked whether a mental disorder lifetime occurred to them and, if so, if 135 
this happened in the past 12 months. At T1, respondents were asked the same questions about mental 136 
disorders, but then the time period referred to mental disorders they had experienced since the baseline 137 
interview.  138 
 139 
Predictor: Pain assessments 140 
At baseline, pain severity was assessed using a question from the SF-36-item Short Form Health Survey 141 
[27]: “How much pain did you experience in the past four weeks?” Respondents could choose between 142 
“no pain”, “very little pain”, “little pain”, “moderate pain”, “severe pain” and “very severe pain”. These 143 
answers were categorised into: 0 = no pain, 1 = very little pain, 2 = little pain, 3 = moderate to very 144 
severe pain. 145 
Interference due to pain was measured with the SF-36 question: “How much interference did you 146 
experience with normal activities (including work outside household, and domestic work) in the past four 147 
weeks as a consequence of pain?”. Respondents could choose between “no interference”, “little 148 
interference”, “moderate interference”, “much interference” and “very much interference”. These answers 149 
were categorised into: 0 = no interference, 1 = little interference, 2 = moderate to very much 150 
interference. Pain severity and interference due to pain were also modelled as continuous variables. The 151 
pain scale of the SF-36, consisting of pain severity and interference due to pain, has a high reliability 152 
[25]; in this study Cronbach’s alpha was 0.84. 153 
 154 
Covariates 155 
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The demographics at baseline were as follows: age in categories (18–24, 25–34, 35–44, 45–54, 55+), 156 
gender, education (primary, lower secondary, higher secondary, higher professional/university), living 157 
situation (with partner or not) and working situation (having a paid job or not). Furthermore, mental 158 
disorders reported at baseline other than the dependent variable in the analysis were selected as 159 
covariates. For example, in the analyses for mood disorder, in which subjects with a mood disorder 12 160 
months prior to baseline were excluded, 12-month anxiety disorder and 12-month substance use 161 
disorder at baseline were selected as covariates. 162 
 163 
Statistical methods 164 
First, cross-sectional analyses were performed to examine baseline differences regarding 165 
sociodemographic characteristics and mental disorders for pain severity and interference due to pain, 166 
for all the 5,303 subjects. Second, logistic regression analyses were performed, for each mental disorder 167 
separately, to examine the risks of both pain severity and pain interference on incidence of the mental 168 
disorder three years later. In all analyses, we first adjusted for demographics and the time between 169 
measurements (model 1) and additionally for other psychopathology at baseline (model 2). For example, 170 
in the fully adjusted model (model 2) to study risk indicators of any incident or recurrent mood, anxiety 171 
and substance use disorder 12 months prior to baseline were included as covariates. Persons with no 172 
pain and persons with no interference due to pain were selected as the reference category. To test for 173 
linear trends in both models, p for trend analyses were conducted. To study whether a previous history 174 
of a mental disorder increases the risk of a mental disorder at 3-year follow-up in persons with pain, 175 
separate interactions of recurrent mood, anxiety and substance use disorders (i.e. those with a lifetime 176 
mental disorder, but who did not report a mental disorder 12 months prior to baseline) and pain (severity 177 
and interference) were tested. Two-tailed testing procedures were used in all analyses with 0.05 alpha 178 
levels, except the interaction analyses, where an alpha of 0.001 was used. All statistical analyses were 179 
performed with Stata version 12.1, using weighted data to ensure they were representative of the national 180 
population. Robust standard errors were calculated to obtain correct 95% confidence intervals and p 181 
values. 182 
 183 
Results 184 
Descriptive data 185 
The baseline characteristics of all 5,303 respondents who participated at the first two waves, tabulated 186 
according to the presence of the two pain characteristics (severity and interference) are shown in Table 187 
1. 188 
-insert Table 1 here- 189 
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Being female, less educated, not having a paid job, and presence of any mood,  anxiety, and substance 190 
use disorder 12 months prior to baseline were significantly associated with a higher score on pain 191 
severity. Female gender, older age, lower education, not having a paid job, presence of any mood and 192 
anxiety disorder 12 months prior to baseline were significantly associated with a higher score on 193 
interference due to pain. 194 
Outcome data and main results 195 
Of the 4974 persons at risk for a mood disorder, 304 developed an incident mood disorder (185 a first-196 
incident disorder and 119 a recurrent disorder) over the next three years. Of the 4979 persons at risk 197 
for an anxiety disorder, 179 developed an incident anxiety disorder (131 a first-incident disorder and 198 
48 a recurrent disorder) over the next three years. Of the 5073 persons at risk for a substance use 199 
disorder, 160 developed an incident substance use disorder (100 a first-incident disorder and 60 a 200 
recurrent disorder) over the next three years. Thus, the majority of incident cases developed a first-201 
incident disorder. 202 
Table 2 shows the odds ratios (OR) for incidence (first-incidence or recurrence) of any mood disorder, 203 
any anxiety disorder and any substance use disorder three years later by pain severity and interference 204 
due to pain at baseline.  205 
-Insert Table 2 here- 206 
Respondent with little pain at baseline (n=784, 14.0%) had a more that two times higher odds of 207 
developing any anxiety disorder three years later (OR=2.33; 95%CI=1.41-3.85), compared to those 208 
without pain. Respondents with moderate to very severe pain at baseline (n=797, 15.1%) had a two times 209 
higher odds of developing any mood disorder (OR=2.10; 95%CI=1.33-3.29) and any anxiety disorder 210 
(OR=2.12; 95%CI=1.27-3.55) at three year follow-up, compared to those without pain. Compared to 211 
model 1, adjusting for the baseline presence of mental disorders other than the dependent variable 212 
(model 2) slightly reduced the effect of baseline severity of pain. Respondents with little interference due 213 
to pain at baseline (n=806, 14.4%) had approximately a two times higher odds of developing any mood 214 
disorder (OR=1.73; 95%CI=1.19-2.53) and any anxiety disorder (OR=1.90; 95%CI=1.21-2.99) at three 215 
year follow-up, compared to those without pain. Respondents with moderate to very severe interference 216 
due to pain at baseline (n=451, 8.3%) also had approximately a two times higher odds of developing any 217 
mood disorder (OR=2.14; 95%CI=1.30-3.54) and any anxiety disorder (OR=1.92; 95%CI=1.05-3.52) 218 
three years later, compared to those without interference due to pain. Compared to model 1, adjusting 219 
for the baseline presence of mental disorders other than the dependent variable (model 2) slightly 220 
reduced the effect of baseline interference due to pain. Both pain characteristics (severity and 221 
interference) at baseline were not significantly associated with any incident or recurrent substance use 222 
disorder at follow-up. The p for trend analyses showed that with higher pain severity and with more 223 
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interference due to pain, the risk of any incident or recurrent mood and anxiety disorder increased (all 224 
models: p<.01). This did not apply for any incident substance use disorders. 225 
No interaction effects were found for a previous history of a mood disorder with pain on the risk of 226 
developing a mood disorder at 3-year follow-up, a previous history of an anxiety disorder with pain on 227 
the risk of developing an anxiety disorder at 3-year follow-up, and a previous history of a substance use 228 
disorder with pain on the risk of developing a substance use disorder at 3-year follow-up. These effects 229 
applied for both pain severity and interference due to pain. This implies that the association between 230 
pain and mental disorders did not significantly differ between subjects with a first onset and subjects 231 
with a recurrent mental disorder. 232 
 233 
Discussion 234 
This is one of the first large scale studies assessing pain as a risk factor for the prospective development 235 
of first or recurrent episodes of common mental disorders in the adult general population. Prevalence of 236 
moderate to very severe pain was 15.1% and for moderate to very severe interference due to pain 8.3%. 237 
These subjects had a more that twofold increased risk for developing a first-incident or recurrent mood 238 
and anxiety disorder three years later. Adjusting for mental disorder at baseline, other than the one as 239 
the dependent variable, only slightly attenuated the strength of the pain-mental disorder associations. 240 
Moreover, the effect of pain on mental disorders did not differ between subjects who developed a first-241 
incident mental disorder and subjects who developed a recurrent mental disorder. Our findings, 242 
therefore, show that pain is a common, strong and unique risk factor for mood and anxiety disorders. 243 
Our findings are consistent with and extend previous longitudinal findings between pain and mood and 244 
anxiety [1,13,14,18]. The strength of the association between pain severity and interference due to pain 245 
with mood and anxiety disorders is higher in the current study compared to previous longitudinal 246 
studies: In clinical studies more severe pain increased the risk for onset of a depressive and anxiety 247 
disorder between a one- to twofold factor [13] and for recurrence of depression by a 1.2-fold factor 248 
[14]; in population studies, among elderly, more severe pain increased the risk for depressive symptoms 249 
by a 1.1-fold factor [18], and more interference due to pain increased the risk for depressive and anxiety 250 
symptoms by almost a twofold factor [1]. In the present study, a more than 2-fold increased risk was 251 
found for both pain severity and interference due to pain in developing a mood and anxiety disorder. 252 
This may be attributed to methodological differences in study sample, study size and outcome measures. 253 
For example, although the population studies [1,18] used non-depressed and non-anxious subjects, 254 
depression and anxiety were measured with a self-report questionnaire regarding symptoms in the last 255 
week. A major contribution of the present study is the use of a standardized diagnostic interview to 256 
assess mental disorders in the last 12-months and lifetime history of mental disorders. This enabled us 257 
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to 1) assess clinical and chronic symptoms of common mental disorders, 2) assess the risk of pain in 258 
subjects without a mental disorder in the last 12 months, and 3) evaluate whether the risk of pain differs 259 
in subjects with a recurrent mental disorder and subjects with a first-onset mental disorder. Our findings 260 
therefore extend previous literature by showing that when pain becomes more severe or interferes with 261 
normal activities, the risk of full-blown first-incident or recurrent mood and anxiety disorders increases 262 
substantially in the general adult population.  263 
Regarding first-incident and recurrence of substance use disorder, we found no association with pain 264 
severity or with interference due to pain at baseline. In a study among at-risk stimulant users, more days 265 
of pain (which interfered with work and social activities) was associated with a two- to threefold increase 266 
of developing a substance use disorder [10]. It could therefore be expected that, in the present study, 267 
interference due to pain would also be associated with substance use disorder. A possible explanation 268 
for this discrepancy might be attributed to several methodological differences. Edlund et al. (2013) [10] 269 
used a sample of at-risk stimulant users, which might not be comparable to the general adult population. 270 
Furthermore, they used a non-validated measure for pain and adjusted their results only for severity of 271 
depression, based on a short self-report questionnaire. However, it could also indicate that pain is a risk 272 
factor for developing a substance use disorder in an at-risk sample, but not in the general adult 273 
population. Nevertheless, Volkow et al. (2016) [26] warn for the possible abuse hazards of opioid use by 274 
chronic pain patients, as opioid analgesics are the most commonly prescribed class of medications for 275 
pain, with a high risk of abuse and addiction. In our study, we were unable to distinguish between specific 276 
substance use disorders, such as opioid use, due to a small number of subjects in this category. 277 
Therefore, in future studies, the specific association between pain, mental disorders and opioid use 278 
should be taken into account.  279 
 280 
Strengths and limitations 281 
This study had the advantage of a large population sample, which was followed-up for three years, the 282 
use of a standardized instrument to assess common mental disorders and the possibility to adjust for a 283 
wide variety of confounders in investigating the relationship between pain characteristics at baseline and 284 
mental disorders at follow-up. However, some limitations have to be mentioned.  285 
The outcome of the main analysis was aggregated as we have pooled both first-incident and recurrent 286 
mental disorders. However, we did examine whether results would differ for subjects with a recurrent 287 
mental disorder from those with a first-incident mental disorder, and found no significant difference. 288 
This might be explained due to the relatively small number of subjects with a recurrent (lifetime) (n=119 289 
for mood; n=48 for anxiety; n=60 for substance use) and first-incident (n=185 for mood; n=131 for 290 
anxiety; n=100 for substance use) mental disorder at follow-up, and studies with larger sample sizes of 291 
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incident and recurrent mental disorders are needed to study this more accurately. Mental disorders were 292 
also aggregated by pooling several specific mood, anxiety and substance use disorders due to the small 293 
numbers reporting a specific mental disorder. As a consequence, no inferences can be made whether 294 
pain is a risk factor in developing one of these specific disorders and in developing another mental 295 
disorder not considered in our study. Additionally, the use of the SF36 to measure pain severity and 296 
interference due to pain is limited. This questionnaire only asks for pain in the last four weeks, so no 297 
inferences could be made on chronic pain. However, in two large clinical studies, chronic pain (pain with 298 
a duration of at least 90 days) was not associated more strongly with the onset and recurrence of a 299 
depressive and anxiety disorder when compared to less chronic pain [13,14], indicating that current 300 
severe pain might be a more important risk factor when considering mental disorders. Despite a follow-301 
up period of three years in this study, we cannot make any inferences about a causal pathway of pain 302 
towards a mental disorder. Besides, it is possible that factors not studied here might play a mediating 303 
role in the link between pain and mental disorders. For example, sleep problems can play a mediating 304 
role in the link between persistent pain and depression and anxiety [8,9]. Dysfunctional cognitive pain 305 
responses, such as catastrophizing or hopelessness, also seem to mediate the association between pain 306 
and depression [19]. In future research and interventions of pain, problems with sleep and dysfunctional 307 
cognitive responses should therefore also be taken into account. Sleep problems and dysfunctional 308 
cognitions are modifiable factors, and when these factors mediate the association between pain and 309 
mental disorders, interventions targeted at sleep and cognitions might also be effective in reducing both 310 
pain and the risk of mental disorders. 311 
 312 
Conclusion/clinical implications 313 
Our finding that pain has a large impact in the development of a mental disorder in the adult general 314 
population is important for health professionals, who would do well by monitoring and detecting possible 315 
symptoms of a mental disorder when pain symptoms are present. Pain management programs could 316 
then possibly also serve as a preventative program for mental disorders in subjects with pain; reducing 317 
pain symptoms might lead to a reduced risk for developing a mental disorder. However, more 318 
longitudinally research is needed exploring causality and other mediating factors in the association 319 
between pain and mental disorders. 320 
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